Artwork

Content provided by Sheree Martin - Media Producer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sheree Martin - Media Producer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Soluble Therapeutics, Inc. - BioTech to Speed Pharma R&D

29:52
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on May 04, 2019 03:34 (5y ago). Last successful fetch was on February 27, 2019 02:36 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 151067379 series 1014259
Content provided by Sheree Martin - Media Producer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sheree Martin - Media Producer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Soluble Therapeutics, Inc. was formed in 2008 to commercialize technogy developed by UAB researchers. This HSC™ Technology helps to deal with a bottleneck in pharmaceutical R&D--the identification of appropriate biologic solutions to deliver protein-based drugs.

In 2010 Dr. Joseph M. Garner came on board as CEO of Soluble Therapeutics, Inc. to lead the commercialization efforts and continue to validate the technology.

Director of Business Development, John McCarter, is the guest of this episode of Ignite Alabama. He began working with Soluble Therapeutics, Inc. in 2010 as an intern and moved through the ranks in business development.

John explains the company's transition from a primary focus on technology validation to the commercialization of the technology and expansion.

He also describes some of the capitalization sources, which have included significant infusion from venture capital funds and a $1 million NIH grant.Soluble Therapeutics, Inc. has a global customer base and John explains how he uses webinars, LinkedIn and other internet-based communications technology to complement his marketing efforts at international conferences. We also talk about the attributes of a 21st century economy and whether Alabama and Birmingham is moving in the right direction.

For more information and business resources, visit http://alabamaignite.com.PDF transcripts of each episode of Ignite Alabama will soon be available for purchase at a nominal price.Ignite Alabama is a Shinecast® podcast developed, produced and hosted by Sheree Martin.

  continue reading

21 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on May 04, 2019 03:34 (5y ago). Last successful fetch was on February 27, 2019 02:36 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 151067379 series 1014259
Content provided by Sheree Martin - Media Producer. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sheree Martin - Media Producer or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Soluble Therapeutics, Inc. was formed in 2008 to commercialize technogy developed by UAB researchers. This HSC™ Technology helps to deal with a bottleneck in pharmaceutical R&D--the identification of appropriate biologic solutions to deliver protein-based drugs.

In 2010 Dr. Joseph M. Garner came on board as CEO of Soluble Therapeutics, Inc. to lead the commercialization efforts and continue to validate the technology.

Director of Business Development, John McCarter, is the guest of this episode of Ignite Alabama. He began working with Soluble Therapeutics, Inc. in 2010 as an intern and moved through the ranks in business development.

John explains the company's transition from a primary focus on technology validation to the commercialization of the technology and expansion.

He also describes some of the capitalization sources, which have included significant infusion from venture capital funds and a $1 million NIH grant.Soluble Therapeutics, Inc. has a global customer base and John explains how he uses webinars, LinkedIn and other internet-based communications technology to complement his marketing efforts at international conferences. We also talk about the attributes of a 21st century economy and whether Alabama and Birmingham is moving in the right direction.

For more information and business resources, visit http://alabamaignite.com.PDF transcripts of each episode of Ignite Alabama will soon be available for purchase at a nominal price.Ignite Alabama is a Shinecast® podcast developed, produced and hosted by Sheree Martin.

  continue reading

21 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide